Prevention of Alzheimer's disease in high risk groups: Statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein e epsilon 4

Daniel A. Pollen, Stephen Baker, Douglas Hinerfeld, Joan Swearer, Barbara A. Evans, James E. Evans, Richard Caselli, Ekaterina Rogaeva, Peter St George-Hyslop, Majaz Moonis

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Prevention of Alzheimer's disease in high risk groups: Statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein e epsilon 4'. Together they form a unique fingerprint.

Medicine & Life Sciences